Nobuya Kitamura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Nobuya Kitamura has a total of 111 co-authors. Here are the top co-authors by number of shared publications:
Atsushi Sakurai
Division of Emergency and Critical Care Medicine, Department of Acute Medicine, Nihon University School of Medicine, Tokyo, Japan
2 shared publications- Masahiro Kashiura
Department of Emergency and Critical Care Medicine, Saitama Medical Center, Jichi Medical University, Saitama-ken, Japan
2 shared publications Munekazu Takeda
Department of Critical Care and Emergency Medicine, Tokyo Women's Medical University, Tokyo, Japan
2 shared publicationsNaoki Shimizu
2 shared publicationsShigeto Oda
2 shared publications- Shunsuke Amagasa
Department of Emergency and Transport Medicine, National Center for Child Health and Development, Tokyo, Japan
2 shared publications
Latest Publications
- Open Access
- 19 October 2026
- Published by Elsevier in Air Medical Journal
Educational Effect of an Air Crew Ditching Course on Helicopter Emergency Medical Service Crew: A Pre–Post Questionnaire Study
- 19 October 2026
- Published by Elsevier in Air Medical Journal
Open AccessEducational Effect of an Air Crew Ditching Course on Helicopter Emergency Medical Service Crew: A Pre–Post Questionnaire Study
- Open Access
- 1 January 2026
- Published by Wiley in Acute Medicine & Surgery
- Vol. 13 (1) , e70150
Prophylactic Antibiotics and 30‐Day Survival in Out‐Of‐Hospital Cardiac Arrest Patients Undergoing VA ‐ ECMO : A Multicenter Observational Study
Background: Patients with out‐of‐hospital cardiac arrest (OHCA) undergoing extracorporeal cardiopulmonary resuscitation with veno‐arterial extracorporeal membrane oxygenation (VA‐ECMO) are at high risk of nosocomial infections, and prophylactic antibiotics may reduce the infections, but there is limited evidence. This study evaluated the effectiveness of prophylactic antibiotic administration on survival and neurological outcomes in patients with OHCA receiving VA‐ECMO. Methods: As a prespecified research question within the Survey of Survivors after Cardiac Arrest in the Kanto Area in 2017 (SOS‐KANTO 2017) study, we conducted a multicenter observational study analyzing 153 patients with OHCA who underwent VA‐ECMO between September 2019 and March 2021. Patients were categorized into the prophylactic antibiotic group ( n = 106) or control group ( n = 47). The primary endpoint was 30‐day survival, and the secondary endpoints were ECMO‐free days and a 30‐day cerebral performance category of 1 or 2. Results: After Inverse Probability of Treatment Weighting (IPTW), the 30‐day survival was significantly higher in the antibiotic group than in the control group (42.8% vs. 20.3%; p < 0.001) and also ECMO‐free days were higher in the antibiotic group (7.1 days vs. 1.4 days; p < 0.001). However, there was no significant difference in neurological outcomes (13.2% vs. 11.1%; p = 0.584). Conclusions: Prophylactic antibiotic administration during VA‐ECMO was associated with improved 30‐day survival in patients with OHCA. Although these findings suggest a potential benefit, further randomized controlled trials are required to establish clinical recommendations.
- 1 January 2026
- Published by Wiley in Acute Medicine & Surgery
- Vol. 13 (1) , e70150
Open AccessProphylactic Antibiotics and 30‐Day Survival in Out‐Of‐Hospital Cardiac Arrest Patients Undergoing VA ‐ ECMO : A Multicenter Observational Study
Background: Patients with out‐of‐hospital cardiac arrest (OHCA) undergoing extracorporeal cardiopulmonary resuscitation with veno‐arterial extracorporeal membrane oxygenation (VA‐ECMO) are at high risk of nosocomial infections, and prophylactic antibiotics may reduce the infections, but there is limited evidence. This study evaluated the effectiveness of prophylactic antibiotic administration on survival and neurological outcomes in patients with OHCA receiving VA‐ECMO. Methods: As a prespecified research question within the Survey of Survivors after Cardiac Arrest in the Kanto Area in 2017 (SOS‐KANTO 2017) study, we conducted a multicenter observational study analyzing 153 patients with OHCA who underwent VA‐ECMO between September 2019 and March 2021. Patients were categorized into the prophylactic antibiotic group ( n = 106) or control group ( n = 47). The primary endpoint was 30‐day survival, and the secondary endpoints were ECMO‐free days and a 30‐day cerebral performance category of 1 or 2. Results: After Inverse Probability of Treatment Weighting (IPTW), the 30‐day survival was significantly higher in the antibiotic group than in the control group (42.8% vs. 20.3%; p < 0.001) and also ECMO‐free days were higher in the antibiotic group (7.1 days vs. 1.4 days; p < 0.001). However, there was no significant difference in neurological outcomes (13.2% vs. 11.1%; p = 0.584). Conclusions: Prophylactic antibiotic administration during VA‐ECMO was associated with improved 30‐day survival in patients with OHCA. Although these findings suggest a potential benefit, further randomized controlled trials are required to establish clinical recommendations.
- 28 April 2022
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 29 (10) , 1057-1083
JPNclinical practice guidelines 2021 with easy‐to‐understand explanations for the management of acute pancreatitis
Background: In preparing the Japanese (JPN) guidelines for the management of acute pancreatitis 2021, the committee focused the issues raised by the results of nationwide epidemiological survey in 2016 in Japan.Method: In addition to a systematic search using the previous JPN guidelines, papers published from January 2014 to September 2019 were searched for the contents to be covered by the guidelines based on the concept of GRADE system.Results: Thirty‐six clinical questions (CQ) were prepared in 15 subject areas. Based on the facts that patients diagnosed with severe disease by both Japanese prognostic factor score and contrast‐enhanced computed tomography (CT) grade had a high fatality rate and that little prognosis improvement after 2 weeks of disease onset was not obtained, we emphasized the importance of Pancreatitis Bundles, which were shown to be effective in improving prognosis, and the CQ sections for local pancreatic complications had been expanded to ensure adoption of a step‐up approach. Furthermore, on the facts that enteral nutrition for severe acute pancreatitis was not started early within 48 h of admission and that unnecessary prophylactic antibiotics was used in almost all cases, we emphasized early enteral nutrition in small amounts even if gastric feeding is used and no prophylactic antibiotics are administered in mild pancreatitis.Conclusion: All the members of the committee have put a lot of effort into preparing the extensively revised guidelines in the hope that more people will have a common understanding and that better medical care will be spread.
- 28 April 2022
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 29 (10) , 1057-1083
JPNclinical practice guidelines 2021 with easy‐to‐understand explanations for the management of acute pancreatitis
Background: In preparing the Japanese (JPN) guidelines for the management of acute pancreatitis 2021, the committee focused the issues raised by the results of nationwide epidemiological survey in 2016 in Japan.Method: In addition to a systematic search using the previous JPN guidelines, papers published from January 2014 to September 2019 were searched for the contents to be covered by the guidelines based on the concept of GRADE system.Results: Thirty‐six clinical questions (CQ) were prepared in 15 subject areas. Based on the facts that patients diagnosed with severe disease by both Japanese prognostic factor score and contrast‐enhanced computed tomography (CT) grade had a high fatality rate and that little prognosis improvement after 2 weeks of disease onset was not obtained, we emphasized the importance of Pancreatitis Bundles, which were shown to be effective in improving prognosis, and the CQ sections for local pancreatic complications had been expanded to ensure adoption of a step‐up approach. Furthermore, on the facts that enteral nutrition for severe acute pancreatitis was not started early within 48 h of admission and that unnecessary prophylactic antibiotics was used in almost all cases, we emphasized early enteral nutrition in small amounts even if gastric feeding is used and no prophylactic antibiotics are administered in mild pancreatitis.Conclusion: All the members of the committee have put a lot of effort into preparing the extensively revised guidelines in the hope that more people will have a common understanding and that better medical care will be spread.
- 1 April 2019
- Published by Elsevier in Resuscitation
- Vol. 137, 161-167
Relationship between institutional case volume and one-month survival among cases of paediatric out-of-hospital cardiac arrest
- 1 April 2019
- Published by Elsevier in Resuscitation
- Vol. 137, 161-167
Relationship between institutional case volume and one-month survival among cases of paediatric out-of-hospital cardiac arrest
- 1 July 2002
- Published by S. Karger AG in Blood Purification
- Vol. 20 (4) , 342-348
Efficacy of Continuous Hemodiafiltration for Patients with Congestive Heart Failure
Background/Aims: The basic principle of treatment of congestive heart failure is achieving adequate control of preload and afterload through enhancement of cardiac contractility. In severe cases, however, we have usually applied continuous hemodiafiltration (CHDF) as a type of mechanical support. In this study, we investigated hemodynamic changes caused by CHDF in patients with congestive heart failure. Methods: We treated seven patients with congestive heart failure complicated by multiple organ failure by CHDF over 72 h, during which we measured hemodynamic parameters to determine their changes. Results: Implementation of CHDF resulted in a significant decrease in pulmonary artery occluded pressure and significant increases in cardiac index and left ventricular stroke work index. In addition, 72-hour cumulative water balance was found to be –1,791 ± 2,119 ml, and systemic vascular resistance index decreased significantly. Conclusion: Hemodynamics of patients were improved with CHDF through strict control of preload and consequently tissue oxygen metabolism was improved.
- 1 July 2002
- Published by S. Karger AG in Blood Purification
- Vol. 20 (4) , 342-348
Efficacy of Continuous Hemodiafiltration for Patients with Congestive Heart Failure
Background/Aims: The basic principle of treatment of congestive heart failure is achieving adequate control of preload and afterload through enhancement of cardiac contractility. In severe cases, however, we have usually applied continuous hemodiafiltration (CHDF) as a type of mechanical support. In this study, we investigated hemodynamic changes caused by CHDF in patients with congestive heart failure. Methods: We treated seven patients with congestive heart failure complicated by multiple organ failure by CHDF over 72 h, during which we measured hemodynamic parameters to determine their changes. Results: Implementation of CHDF resulted in a significant decrease in pulmonary artery occluded pressure and significant increases in cardiac index and left ventricular stroke work index. In addition, 72-hour cumulative water balance was found to be –1,791 ± 2,119 ml, and systemic vascular resistance index decreased significantly. Conclusion: Hemodynamics of patients were improved with CHDF through strict control of preload and consequently tissue oxygen metabolism was improved.